Moorfields Eye Hospital is a specialist NHS eye hospital in Finsbury in the London Borough of Islington in London, England run by Moorfields Eye Hospital NHS Foundation Trust.

During the past decade, Moorfields Eye Hospital conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 29 clinical trials were completed, i.e. on average, 25.4% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 23 clinical trials were completed. i.e. 44.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moorfields Eye Hospital" #1 sponsor was "Moorfields Eye Hospital NHS Foundation Trust" with 31 trials, followed by "MeiraGTx UK II Ltd" with 12 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "University College, London" with 8 trials sponsored and "Boehringer Ingelheim" with 8 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moorfields Eye Hospital" #1 collaborator was "Moorfields Eye Hospital NHS Foundation Trust" with 13 trials as a collaborator, "University College, London" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator, "Janssen Research & Development, LLC" with 4 trials as a collaborator and "City, University of London" with 3 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Moorfields Eye Hospital" are "Diabetic Retinopathy" (11 trials), "Diabetic Macular Edema" (10 trials), "Eye Diseases" (8 trials), "Uveitis" (8 trials) and "Retinitis Pigmentosa" (7 trials). Many other conditions were trialed in "Moorfields Eye Hospital" in a lesser frequency.

Most popular intervention types in "Moorfields Eye Hospital" are "Drug" (63 trials), "Other" (28 trials), "Device" (27 trials), "Biological" (18 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Sham Procedure" (8 trials), "Ranibizumab" (6 trials), "Sham" (5 trials) and "Aflibercept" (4 trials). Other intervention names were less common.

The vast majority of trials in "Moorfields Eye Hospital" are 141 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are 57 active trials in "Moorfields Eye Hospital". 3 are not yet recruiting, 29 are recruiting, 23 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 73 completed trials in Moorfields Eye Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Moorfields Eye Hospital, 22 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 21 trials that are defined as “Not Applicable".